Share on StockTwits

Heat Biologics (NASDAQ:HTBX) posted its quarterly earnings results on Thursday. The company reported ($0.44) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.40) by $0.04, Stock Ratings Network.com reports.

Shares of Heat Biologics (NASDAQ:HTBX) opened at 3.96 on Thursday. Heat Biologics has a one year low of $3.60 and a one year high of $15.29. The stock has a 50-day moving average of $4.52 and a 200-day moving average of $5.61. The company’s market cap is $25.5 million.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.